51.97 0.00 (0.00%)
After hours: 4:17PM EDT
|Bid||51.95 x 1100|
|Ask||51.94 x 800|
|Day's Range||51.82 - 51.97|
|52 Week Range||25.02 - 52.58|
|Beta (3Y Monthly)||1.66|
|PE Ratio (TTM)||24.99|
|Forward Dividend & Yield||0.32 (0.62%)|
|1y Target Est||N/A|
Merck KGaA ("Merck") announced that its transaction with Versum Materials, Inc ("Versum") had been approved at a special meeting among Versum's shareholders. Merck had signed a definitive agreement to acquire Versum for a consideration of $53 in cash in April this year, notes Moody's.
The German biotech and chemicals company intends to maintain Versum’s Tempe headquarters as the major hub for its combined electronic materials business in the U.S.
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]
Versum Materials Inc NYSE:VSMView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for VSM with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting VSM. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $3.04 billion over the last one-month into ETFs that hold VSM are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Basic Materials sector is rising. The rate of growth is weak relative to the trend shown over the past year, but is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Mason Capital is a New York-based asset management firm that was launched by Kenneth Mario Garschina in 2000. It provides an additional office in London England. On March 28th, 2017, the fund managed around $3.5 billion in assets. Before launching his own hedge fund, Mr. Garschina worked at KS Capital Partners, first as a Research […]
FRANKFURT (Reuters) - Germany's Merck KGaA, which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth ...
In April, Versum rejected a previous merger deal with a U.S. company in order to proceed with the buyout by Merck KGaA.
Versum Materials (VSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Versum Materials (VSM) delivered earnings and revenue surprises of 0.00% and -3.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]
NOTE: On April 17, 2019, the press release was corrected as follows: In the third sentence, the description of the affirmed rating was changed to short term issuer rating. Revised release follows. Paris, April 16, 2019 -- Moody's Investors Service, ("Moody's") has today affirmed Merck KGaA's ('Merck') issuer rating, senior unsecured Medium Term Note and subordinated ratings at Baa1, (P)Baa1 and Baa3 respectively.
The companies have inked their definitive merger agreement, and regulatory filings show that several more Versum executives will be eligible to receive hefty bonuses after the deal is consummated.
The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release. Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment.
Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
After last-minute whirlwind trans-Atlantic negotiations, Tempe's Versum Materials Inc. has said it wants to pull out of a deal to merge with a U.S. company in order to be acquired by a much larger German corporation.
Announcement: Moody's says revised proposal from Merck KGaA is credit positive for Versum. Global Credit Research- 09 Apr 2019. New York, April 09, 2019-- Moody's Investors Service commented on the announcement ...
Versum Materials, Inc . (NYSE: VSM ) announced Monday that it received a revised proposal from Merck KGaA to acquire Versum for $53 per share, up from Merck's prior $48-per-share proposal on Feb. 27. ...
Merck KGaA won the backing of Versum's board for a sweetened $6.5 billion (4.98 billion pounds) takeover proposal, overturning an agreed merger with rival Entegris as it bets on a recovery in electronic materials markets. "This proposal constitutes a 'Superior Proposal' as defined in Versum's previously announced merger agreement with Entegris, Inc.," Versum said in a statement on Monday. On a per share basis, Germany's Merck offered $53, up from $48 previously, after reviewing business data and following meetings between Merck Chief Executive Stefan Oschmann and Versum Chairman Seifi Ghasemi, filings showed.
Though Versum has said its board rejects a hostile takeover bid by Merck KGaA, company officials are continuing negotiations with the German suitor.
"Merck’s proposal could reasonably be expected to result in a superior proposal," Versum, a maker of chemicals for the semiconductor industry, cited its board as saying in a statement on Friday. The board "has authorized Versum's management and its advisers to engage in further discussions with, and provide non-public information to, Merck," the statement added.